Export 2751 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
M. A. Thera, Doumbo, O. K., Coulibaly, D., Laurens, M. B., Kone, A. K., Guindo, A. B., Traore, K., Sissoko, M., Diallo, D. A., Diarra, I., Kouriba, B., Daou, M., Dolo, A., Baby, M., Sissoko, M. S., Sagara, I., Niangaly, A., Traore, I., Olotu, A., Godeaux, O., Leach, A., Dubois, M. - C., W Ballou, R., Cohen, J., Thompson, D., Dube, T., Soisson, L., Diggs, C. L., Takala, S. L., Lyke, K. E., House, B., Lanar, D. E., Dutta, S., D Heppner, G., and Plowe, C. V., Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial., PLoS One, vol. 5, no. 2, p. e9041, 2010.
M. Thera, Doumbo, O., Coulibaly, D., Laurens, M., Kone, A., Guindo, A., Traore, K., Traore, I., Kouriba, B., Diallo, D., Diarra, I., Daou, M., Dolo, A., Tolo, Y., Sissoko, M., Niangaly, A., ,, Thompson, D., Dube, T., Soisson, L., Diggs, C., House, B., Lanar, D., and Dutta, S., A Field Trial to Assess a Blood-Stage Malaria Vaccine, N Engl J Med, vol. 365, pp. 1004-1013, 2011.
M. A. Thera, Doumbo, O. K., Coulibaly, D., Laurens, M. B., Ouattara, A., Kone, A. K., Guindo, A. B., Traore, K., Traore, I., Kouriba, B., Diallo, D. A., Diarra, I., Daou, M., Dolo, A., Tolo, Y., Sissoko, M. S., Niangaly, A., Sissoko, M., Takala-Harrison, S., Lyke, K. E., Wu, Y., Blackwelder, W. C., Godeaux, O., Vekemans, J., Dubois, M. - C., W Ballou, R., Cohen, J., Thompson, D., Dube, T., Soisson, L., Diggs, C. L., House, B., Lanar, D. E., Dutta, S., D Heppner, G., and Plowe, C. V., A field trial to assess a blood-stage malaria vaccine., N Engl J Med, vol. 365, no. 11, pp. 1004-13, 2011.
M. Thill, Strunnikova, N. V., Berna, M. J., Gordiyenko, N., Schmid, K., Cousins, S. W., Thompson, D. J. S., and Csaky, K. G., Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration., Invest Ophthalmol Vis Sci, vol. 49, no. 6, pp. 2696-708, 2008.
M. Thill, Strunnikova, N., Berna, M., Gordiyenko, N., Schmid, K., Cousins, S., Thompson, D., and Csaky, K., Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration, Invest Ophthalmol Vis Sci, vol. 49, pp. 2696-2708, 2008.
P. R. Thomas, Stablein, D. M., Steinberg, S. M., Barkin, J. S., and Nauta, R. J., The effects of liver directed radiotherapy and chemotherapy on liver function tests and hematological parameters in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group., Am J Gastroenterol, vol. 82, no. 8, pp. 738-43, 1987.
P. R. Thomas, Stablein, D. M., Kinzie, J. J., Novak, J. W., Childs, D. S., Knowlton, A. H., and Mittelman, A., Perineal effects of postoperative treatment for adenocarcinoma of the rectum., Int J Radiat Oncol Biol Phys, vol. 12, no. 2, pp. 167-71, 1986.
P. R. Thomas, Lindblad, A. S., Stablein, D. M., Knowlton, A. H., Bruckner, H. W., Childs, D. S., and Mittelman, A., Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum., Cancer, vol. 57, no. 6, pp. 1130-4, 1986.
D. J. S. Thompson and Dean, C. B., Imputation using Longitudinal Data in Interval-Censored Survival Data. Fort Collins, CO, 2010.
D. J. S. Thompson, Barron, K. S., Whitcup, S. M., and Robinson, M. R., The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis., Ocul Immunol Inflamm, vol. 10, no. 2, pp. 83-91, 2002.
D. J. S. Thompson, Barron, K., Whitcup, S., and Robinson, M., The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis, Ocular Immunology & Inflammation, vol. 10, pp. 83-91, 2002.
V. P. Thompson, Schenkel, A. B., Penugonda, B., Wolff, M. S., Zeller, G. G., Wu, H., Vena, D., Grill, A. C., and Curro, F. A., A pilot study of dentists' assessment of caries detection and staging systems applied to early caries: PEARL Network findings., Gen Dent, vol. 64, no. 3, pp. 20-7, 2016.
E. J. Thompson, Wu, H., Melloni, C., Balevic, S., Sullivan, J. E., Laughon, M., Clark, K. M., Kalra, R., Mendley, S., Payne, E. H., Erinjeri, J., Gelber, C. E., Harper, B., Cohen-Wolkowiez, M., and Hornik, C. P., Population Pharmacokinetics of Doxycycline in Children., Antimicrob Agents Chemother, 2019.
D. J. S. Thompson, Joint Models, in Encyclopedia of Environmetrics, 2ndnd ed., , Ed. Chichester, UK: John Wiley & Sons, Ltd., 2012, pp. 1405-1408.
H. Tillman, S Johnston, C., Farrant, M., Barsan, W., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., and J Easton, D., Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial., JAMA Neurol, vol. 76, no. 7, pp. 774-782, 2019.
A. K. Tisdale, Agrón, E., Sunshine, S. B., Clemons, T. E., Ferris, F. L., and Chew, E. Y., Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39., JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
J. Tiwari, Schneider, B., Barton, F., and Anderson, S., Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Clinical Outcomes in Data from the Collaborative Islet Transplant Registry (CITR), in The 2012 Joint Statistical Meetings, San Diego, CA, 2012.
J. L. Tiwari, Schneider, B., Barton, F., and Anderson, S. A., Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Efficacy Outcomes and Considerations for Trial Designs, Am J Transplant, vol. 12, pp. 1898-1907, 2012.
J. L. Tiwari, Schneider, B., Barton, F., and Anderson, S. A., Islet cell transplantation in type 1 diabetes: an analysis of efficacy outcomes and considerations for trial designs., Am J Transplant, vol. 12, no. 7, pp. 1898-907, 2012.
B. Tock, Zwiebel, J. A., and Schoenfeldt, M., Clinical trials referral resource. Current clinical trials of G3139., Oncology (Williston Park), vol. 17, no. 9, pp. 1244-6, 1251-3, 1258, 2003.
S. M. Tolaney, Garrett-Mayer, E., White, J., Blinder, V. S., Foster, J. C., Amiri-Kordestani, L., E Hwang, S., Bliss, J. M., Rakovitch, E., Perlmutter, J., Spears, P. A., Frank, E., Tung, N. M., Elias, A. D., Cameron, D., Denduluri, N., Best, A. F., DiLeo, A., Baizer, L., Butler, L. Pearson, Schwartz, E., Winer, E. P., and Korde, L. A., Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0., J Clin Oncol, p. JCO2003613, 2021.
J. Tolar, H Deeg, J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., Difronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels., Biol Blood Marrow Transplant, vol. 18, no. 7, pp. 1007-11, 2012.
J. Tolar, Deeg, H. J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., Difronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
M. Tomblyn, Ewell, M., Bredeson, C., Kahl, B., Goodman, S., Horowitz, M., Vose, J., Negrin, R., and Laport, G., Autologous vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response, Biol Blood Marrow Transplant, vol. 17, pp. 1051-1057, 2011.
M. R. Tomblyn, Ewell, M., Bredeson, C., Kahl, B. S., Goodman, S. A., Horowitz, M. M., Vose, J. M., Negrin, R. S., and Laport, G. G., Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response., Biol Blood Marrow Transplant, vol. 17, no. 7, pp. 1051-7, 2011.